| Methods | D: crossover C: unclear B: double WD: 1/20 J: 1‐1‐1 DU: ‐/3x4w (1w)/‐ | |
| Participants | N: 20/19 D: 3 migraine with, 17 without aura C: Ad Hoc F: 70% A: 15‐60 years DU: not reported S: unclear, Norway | |
| Interventions | P: 160 mg C1: Placebo C2: d‐propranolol 160 mg | |
| Outcomes | R: not reported F: 5.0 (sd 3.7) vs. 6.1 (4.1) vs. 6.2 (4.6) AU: not reported HI: 7.5 vs. 12.3 vs. 10.9 AEs: not reported Dropouts‐AEs: 1/20 vs. 0/20 vs. 0/20 V: + vs. C1, (+) vs. C2 | |
| Notes | No headache diary | |
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Allocation concealment (selection bias) | Unclear risk | B ‐ Unclear |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.